# DoubleDay Acquisitions dba CSAFE Global – FDA Inspection, Dec 10, 2018

Source: https://www.keypedia.com/records/fda_inspections/doubleday-acquisitions-dba-csafe-global/bcbca942-a76d-476a-a3d6-633331a85a34
Source feed: FDA_Inspections

> FDA inspection 1074006 of DoubleDay Acquisitions dba CSAFE Global, December 10, 2018. Classification: No Action Indicated (NAI). 4 citations under 21 CFR part 820. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1074006
- Company Name: DoubleDay Acquisitions dba CSAFE Global
- Inspection Date: 2018-12-10
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 4

## Related Documents

- FDA Inspection 1215859 - 2023-07-25
- [FDA Inspection 938778 - 2015-08-04](https://www.keypedia.com/records/fda_inspections/doubleday-acquisitions-dba-csafe-global/ec3a1c0a-34ab-4b55-b730-0e64dfbb8435)

## Related Officers

- Teresa K. Kastner

Company: https://www.keypedia.com/companies/doubleday-acquisitions-dba-csafe-global/bfc0de1a-ce9a-4ebf-93cc-553c98d3c4cd

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7
